First Trust Advisors LP Raises Stock Position in Mettler-Toledo International, Inc. $MTD

First Trust Advisors LP increased its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 1.3% in the second quarter, Holdings Channel reports. The firm owned 33,900 shares of the medical instruments supplier’s stock after acquiring an additional 448 shares during the period. First Trust Advisors LP’s holdings in Mettler-Toledo International were worth $39,823,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. WPG Advisers LLC acquired a new position in shares of Mettler-Toledo International during the first quarter worth about $41,000. NewSquare Capital LLC lifted its position in Mettler-Toledo International by 94.4% during the 2nd quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock worth $41,000 after acquiring an additional 17 shares in the last quarter. MV Capital Management Inc. boosted its holdings in Mettler-Toledo International by 50.0% in the 2nd quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock worth $42,000 after acquiring an additional 12 shares during the period. Zions Bancorporation National Association UT acquired a new stake in Mettler-Toledo International in the first quarter valued at approximately $43,000. Finally, Sound Income Strategies LLC raised its stake in shares of Mettler-Toledo International by 477.8% during the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock valued at $61,000 after purchasing an additional 43 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Patrick Kaltenbach sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $1,462.50, for a total transaction of $2,925,000.00. Following the completion of the transaction, the chief executive officer directly owned 3,670 shares of the company’s stock, valued at approximately $5,367,375. This represents a 35.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Shawn Vadala sold 1,895 shares of the firm’s stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total value of $2,758,210.40. Following the completion of the sale, the chief financial officer directly owned 5,288 shares in the company, valued at approximately $7,696,789.76. This trade represents a 26.38% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 19,565 shares of company stock valued at $28,683,737 over the last 90 days. 0.77% of the stock is owned by corporate insiders.

Analyst Ratings Changes

MTD has been the subject of several analyst reports. The Goldman Sachs Group began coverage on shares of Mettler-Toledo International in a research note on Tuesday. They issued a “neutral” rating and a $1,475.00 target price for the company. Wells Fargo & Company upped their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday, November 10th. Bank of America raised their target price on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. JPMorgan Chase & Co. increased their price target on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a report on Thursday, October 9th. Finally, Citigroup lifted their price objective on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Five investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $1,424.17.

Mettler-Toledo International Price Performance

MTD stock opened at $1,371.94 on Wednesday. The firm has a market cap of $28.03 billion, a price-to-earnings ratio of 34.21, a PEG ratio of 4.46 and a beta of 1.40. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,525.17. The firm has a fifty day moving average price of $1,395.79 and a two-hundred day moving average price of $1,288.40.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The business had revenue of $1.03 billion during the quarter, compared to analyst estimates of $997.36 million. During the same period in the previous year, the business posted $10.21 EPS. The company’s quarterly revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. As a group, analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.